Skip to main content
OpenTrials
Completed

NCT Number: NCT01623479

An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes

This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Eyelash Hypotrichosis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Santa Ana, California, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hypotrichosis of the eyelashes
  • Using bimatoprost ophthalmic solution 0.03% (Latisse®) for at least 12 months

Exclusion criteria

  • Use of any over-the-counter medication(s) for eyelash growth

Treatment and study plan

bimatoprost 0.03%

Drug

Subjects with hypotrichosis of the eyelashes using bimatoprost 0.03% (Latisse®) as prescribed by physician for at least 12 months

Other names: Latisse®

Primary outcomes

  1. Percentage of Subjects Satisfied With Latisse®

    Time frame: Day 1

    Overall subject satisfaction with Latisse® was assessed on a 5-point scale (Very Satisfied, Satisfied, Neutral, Unsatisfied, and Very Unsatisfied). The percentage of subjects satisfied and very satisfied is reported.

Secondary outcomes

  1. Number of Applications of Latisse® Per Week

    Time frame: Day 1

    Number of applications of Latisse® per week as reported by the subjects.

  2. Percentage of Subjects Satisfied Wtih Their Eyelashes

    Time frame: Day 1

    Overall subject satisfaction with their eyelashes was assessed on a 5-point scale (Very Satisfied, Satisfied, Neutral, Unsatisfied, and Very Unsatisfied). The percentage of subjects satisfied and very satisfied is reported.

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Jun 20, 2012
Registry last updated
Apr 16, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.